These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 22943415)

  • 1. Mass spectrometry for translational proteomics: progress and clinical implications.
    Baker ES; Liu T; Petyuk VA; Burnum-Johnson KE; Ibrahim YM; Anderson GA; Smith RD
    Genome Med; 2012; 4(8):63. PubMed ID: 22943415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry.
    Yocum AK; Chinnaiyan AM
    Brief Funct Genomic Proteomic; 2009 Mar; 8(2):145-57. PubMed ID: 19279071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.
    Wang H; Shi T; Qian WJ; Liu T; Kagan J; Srivastava S; Smith RD; Rodland KD; Camp DG
    Expert Rev Proteomics; 2016; 13(1):99-114. PubMed ID: 26581546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in mass spectrometry based clinical proteomics: applications to cancer research.
    Macklin A; Khan S; Kislinger T
    Clin Proteomics; 2020; 17():17. PubMed ID: 32489335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery.
    Elschenbroich S; Kislinger T
    Mol Biosyst; 2011 Feb; 7(2):292-303. PubMed ID: 20976349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted mass spectrometry approaches for protein biomarker verification.
    Meng Z; Veenstra TD
    J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress in capillary electrophoresis-based high-sensitivity proteomics].
    Yang Y; Tian R
    Se Pu; 2020 Oct; 38(10):1125-1132. PubMed ID: 34213109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.
    Manes NP; Nita-Lazar A
    J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging mass spectrometry-based proteomics methodologies for novel biomedical applications.
    Pino LK; Rose J; O'Broin A; Shah S; Schilling B
    Biochem Soc Trans; 2020 Oct; 48(5):1953-1966. PubMed ID: 33079175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry-based proteomics: existing capabilities and future directions.
    Angel TE; Aryal UK; Hengel SM; Baker ES; Kelly RT; Robinson EW; Smith RD
    Chem Soc Rev; 2012 May; 41(10):3912-28. PubMed ID: 22498958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a pharmaceutical hepatotoxicity biomarker panel using a discovery to targeted proteomics approach.
    Collins BC; Miller CA; Sposny A; Hewitt P; Wells M; Gallagher WM; Pennington SR
    Mol Cell Proteomics; 2012 Aug; 11(8):394-410. PubMed ID: 22527513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing translational research and precision medicine with targeted proteomics.
    Uzozie AC; Aebersold R
    J Proteomics; 2018 Oct; 189():1-10. PubMed ID: 29476807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shotgun proteomics and biomarker discovery.
    McDonald WH; Yates JR
    Dis Markers; 2002; 18(2):99-105. PubMed ID: 12364816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
    de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
    Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition.
    Vidova V; Spacil Z
    Anal Chim Acta; 2017 Apr; 964():7-23. PubMed ID: 28351641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of mass spectrometry-based proteomics to understanding epigenetics.
    Noberini R; Sigismondo G; Bonaldi T
    Epigenomics; 2016 Mar; 8(3):429-45. PubMed ID: 26606673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted proteomics: a bridge between discovery and validation.
    Harlan R; Zhang H
    Expert Rev Proteomics; 2014 Dec; 11(6):657-61. PubMed ID: 25348939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD.
    Hedl TJ; San Gil R; Cheng F; Rayner SL; Davidson JM; De Luca A; Villalva MD; Ecroyd H; Walker AK; Lee A
    Front Neurosci; 2019; 13():548. PubMed ID: 31244593
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.